Canada has become the first G7 nation to approve a generic version of semaglutide, the active ingredient in popular weight-loss and diabetes medications Ozempic and Wegovy. This move, which is expected to make the drugs significantly more affordable for Canadians, contrasts sharply with the situation in the United States, where similar low-cost alternatives are not […]